Prescott Group Capital Management’s Emergent Biosolutions EBS Stock Holding History

Prescott Group Capital Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.48M	Hold	772,771	–	–	0.56%	49
2026 Q1	$6.41M	Hold	772,771	–	–	0.64%	44
2025 Q4	$9.55M	Hold	772,771	–	–	0.89%	21
2025 Q3	$6.82M	Hold	772,771	–	–	0.72%	29
2025 Q2	$4.93M	Buy	772,771 +145,100	+23%	+$830K	0.58%	40
2025 Q1	$3.05M	Buy	627,671 +417,671	+199%	+$3.46M	0.44%	71
2024 Q4	$2.01M	Buy	210,000 +150,000	+250%	+$1.38M	0.27%	116
2024 Q3	$501K	Buy	+60,000	New	+$545K	0.07%	199
2024 Q1	–	Sell	-853,349	Closed	-$2.05M	–	209
2023 Q4	$2.05M	Buy	853,349 +554,162	+185%	+$1.3M	0.36%	87
2023 Q3	$1.02M	Sell	299,187 -7,651	-2%	-$42.4K	0.23%	113
2023 Q2	$2.25M	Buy	+306,838	New	+$2.85M	0.49%	59
2023 Q1	–	Sell	-91,000	Closed	-$1.07M	–	176
2022 Q4	$1.07M	Buy	+91,000	New	+$1.41M	0.23%	106
2022 Q1	–	Sell	-45,693	Closed	-$1.99M	–	155
2021 Q4	$1.99M	Buy	+45,693	New	+$2.07M	0.45%	68

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

OHA

Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

Prescott Group Capital Management's EBS Position: Q2 2026 in Review

Prescott Group Capital Management held its Emergent Biosolutions (EBS) position steady in Q2 2026 at 772,771 shares worth $6.48M. The position accounts for 0.56% of the portfolio, ranked #49.

Prescott Group Capital Management first reported a position in EBS in Q4 2021 and has held it in 13 quarters since. The position peaked at $9.55M in Q4 2025. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

Prescott Group Capital Management held 772,771 shares of Emergent Biosolutions worth $6.48M as of Q2 2026.
Prescott Group Capital Management left its Emergent Biosolutions share count unchanged in Q2 2026.
Emergent Biosolutions made up 0.56% of Prescott Group Capital Management's portfolio in Q2 2026, its #49 holding.
Prescott Group Capital Management first reported a position in Emergent Biosolutions in Q4 2021 and has held it in 13 quarters since.
Prescott Group Capital Management's Emergent Biosolutions position peaked at $9.55M in Q4 2025.
195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on Prescott Group Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.